Glades Drugs Recalls Compounded Multivitamins Due to Potential Vitamin D Toxicity

Pahokee, Florida-based Glades Drugs is recalling compounded multivitamins due to the risk of vitamin D toxicity, the U.S. Food and Drug Administration (FDA) stated in a Nov. 25 safety alert. The compounded capsules may contain excessive amounts of Vitamin D3, also known as Cholecalciferol. The recall was issued after the FDA received several adverse event reports related to the compounded multivitamins.

The FDA warned that “Consumption of this product may result in vitamin D toxicity, which may be severe and may lead to life-threatening outcomes if left untreated.” The agency also noted that symptoms may not appear immediately. Patients who have Glades Drugs’ compounded multivitamin capsules are urged to stop taking them and seek medical attention immediately.

Short-term vitamin D toxicity is a result of excess calcium, or hypercalcemia. Symptoms include confusion, increased urination, increased thirst, loss of appetite, vomiting and muscle weakness, according to the FDA notification. Acute hypercalcemia can also exacerbate heart arrhythmias and seizures. The effects of certain heart drugs may also be increased. Long-term effects can include kidney failure, increase in calcium deposits in the blood and soft tissue, bone demineralization and pain. The risk of vitamin D toxicity is higher among patients with conditions such as liver disease or chronic kidney failure.

from Parker Waichman http://www.yourlawyer.com/blog/glades-drugs-recalls-compounded-multivitamins-due-to-potential-vitamin-d-toxicity/